Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non‐inferiority trial

BACKGROUND AND AIMS: Cytisine, a nicotinic acetylcholine receptor partial agonist (like varenicline) found in some plants, is a low‐cost, effective smoking cessation medication that may appeal to Māori [the indigenous people of New Zealand (NZ)]. The RAUORA trial aims to determine the effectiveness,...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Natalie, Smith, Barry, Barnes, Joanne, Verbiest, Marjolein, Kurdziel, Tomasz, Parag, Varsha, Pokhrel, Subhash, Bullen, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587772/
https://www.ncbi.nlm.nih.gov/pubmed/30276931
http://dx.doi.org/10.1111/add.14449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587772/
https://www.ncbi.nlm.nih.gov/pubmed/30276931
http://dx.doi.org/10.1111/add.14449

Ejemplares similares